125 related articles for article (PubMed ID: 9065910)
1. The uptake of Mn-DPDP by hepatocytes is not mediated by the facilitated transport of pyridoxine.
Gallez B; Baudelet C; Adline J; Charbon V; Lambert DM
Magn Reson Imaging; 1996; 14(10):1191-5. PubMed ID: 9065910
[TBL] [Abstract][Full Text] [Related]
2. Evidence for the dissociation of the hepatobiliary MRI contrast agent Mn-DPDP.
Gallez B; Bacic G; Swartz HM
Magn Reson Med; 1996 Jan; 35(1):14-9. PubMed ID: 8771018
[TBL] [Abstract][Full Text] [Related]
3. MRI measurement of hepatocyte toxicity using the new MRI contrast agent manganese dipyridoxal diphosphate, a manganese/pyridoxal 5-phosphate chelate.
Young SW; Simpson BB; Ratner AV; Matkin C; Carter EA
Magn Reson Med; 1989 Apr; 10(1):1-13. PubMed ID: 2502699
[TBL] [Abstract][Full Text] [Related]
4. Effect of manganese dipyridoxal diphosphate on liver magnetic resonance imaging and serum bilirubin in rats with removable biliary obstruction.
Ni Y; Petré C; Lukito G; Marchal G; Grant D; Gray TJ; Baert AL
Acad Radiol; 1995 Apr; 2(4):300-5. PubMed ID: 9419566
[TBL] [Abstract][Full Text] [Related]
5. Effects of MnDPDP, DPDP--, and MnCl2 on cardiac energy metabolism and manganese accumulation. An experimental study in the isolated perfused rat heart.
Brurok H; Schjøtt J; Berg K; Karlsson JO; Jynge P
Invest Radiol; 1997 Apr; 32(4):205-11. PubMed ID: 9101355
[TBL] [Abstract][Full Text] [Related]
6. Accumulation of manganese in the brain of mice after intravenous injection of manganese-based contrast agents.
Gallez B; Baudelet C; Adline J; Geurts M; Delzenne N
Chem Res Toxicol; 1997 Apr; 10(4):360-3. PubMed ID: 9114970
[TBL] [Abstract][Full Text] [Related]
7. Enhancement of the normal pancreas: comparison of manganese-DPDP and gadolinium chelate.
Kettritz U; Warshauer DM; Brown ED; Schlund JF; Eisenberg LB; Semelka RC
Eur Radiol; 1996; 6(1):14-8. PubMed ID: 8797944
[TBL] [Abstract][Full Text] [Related]
8. Role of exocrine cells in pancreatic enhancement using Mn-DPDP-enhanced MR imaging.
Gong J; Xu J; Zhou K; Shen K
Chin Med J (Engl); 2002 Sep; 115(9):1363-6. PubMed ID: 12411113
[TBL] [Abstract][Full Text] [Related]
9. Pancreatic enhancement after low-dose infusion of Mn-DPDP.
Gehl HB; Vorwerk D; Klose KC; Günther RW
Radiology; 1991 Aug; 180(2):337-9. PubMed ID: 1906189
[TBL] [Abstract][Full Text] [Related]
10. Mn-DPDP enhancement patterns of hepatocellular lesions on MR images.
Vogl TJ; Hamm B; Schnell B; McMahon C; Branding G; Lissner J; Wolf KJ
J Magn Reson Imaging; 1993; 3(1):51-8. PubMed ID: 8381314
[TBL] [Abstract][Full Text] [Related]
11. Detection of hepatic malignancies using Mn-DPDP (manganese dipyridoxal diphosphate) hepatobiliary MRI contrast agent.
Young SW; Bradley B; Muller HH; Rubin DL
Magn Reson Imaging; 1990; 8(3):267-76. PubMed ID: 2114511
[TBL] [Abstract][Full Text] [Related]
12. Uptake of MnCl2 and mangafodipir trisodium in the myocardium: a magnetic resonance imaging study in pigs.
Eriksson R; Johansson L; Bjerner T; Briley Saebo K; Ahlström H
J Magn Reson Imaging; 2004 May; 19(5):564-9. PubMed ID: 15112305
[TBL] [Abstract][Full Text] [Related]
13. [The clinical value of Mn-DPDP: a new paramagnetic hepatobiliary contrast medium for magnetic resonance tomography of the liver].
Vogl TJ; Hamm B; Schnell B; Eibl-Eibesfeldt B; Steiner S; Lissner J
Rofo; 1991 Dec; 155(6):568-74. PubMed ID: 1764599
[TBL] [Abstract][Full Text] [Related]
14. Plasma pharmacokinetics, tissue distribution and excretion of MnDPDP in the rat and dog after intravenous administration.
Hustvedt SO; Grant D; Southon TE; Zech K
Acta Radiol; 1997 Jul; 38(4 Pt 2):690-9. PubMed ID: 9245964
[TBL] [Abstract][Full Text] [Related]
15. The uptake of manganese dipyridoxal-diphosphate by chemically induced hepatocellular carcinoma in rats. A correlation between contrast-media-enhanced magnetic resonance imaging, tumor differentiation, and vascularization.
Ni Y; Marchal G; Zhang X; Van Hecke P; Michiels J; Yu J; Rummeny E; Lodemann KP; Baert AL
Invest Radiol; 1993 Jun; 28(6):520-8. PubMed ID: 8320070
[TBL] [Abstract][Full Text] [Related]
16. Comparison between Gd-DTPA, Gd-EOB-DTPA, and Mn-DPDP in induced HCC in rats: a correlation study of MR imaging, microangiography, and histology.
Marchal G; Zhang X; Ni Y; Van Hecke P; Yu J; Baert AL
Magn Reson Imaging; 1993; 11(5):665-74. PubMed ID: 8345781
[TBL] [Abstract][Full Text] [Related]
17. Comparison of contrast enhanced CT and Mn-DPDP enhanced MRI for detection of focal hepatic lesions. Initial findings.
Birnbaum BA; Weinreb JC; Fernandez MP; Brown JJ; Rofsky NM; Young SW
Clin Imaging; 1994; 18(1):21-7. PubMed ID: 8180855
[TBL] [Abstract][Full Text] [Related]
18. Mn-DPDP enhanced MRI in experimental bile duct obstruction.
Marchal G; Ni Y; Zhang X; Yu J; Lodemann KP; Baert AL
J Comput Assist Tomogr; 1993; 17(2):290-6. PubMed ID: 8454757
[TBL] [Abstract][Full Text] [Related]
19. Mn-DPDP-enhanced MR imaging of malignant liver lesions: efficacy and safety in 20 patients.
Aicher KP; Laniado M; Kopp AF; Grönewäller E; Duda SH; Claussen CD
J Magn Reson Imaging; 1993; 3(5):731-7. PubMed ID: 8400558
[TBL] [Abstract][Full Text] [Related]
20. A novel manganese chelated macromolecular MRI contrast agent based on O-carboxymethyl chitosan derivatives.
Wang X; Xu L; Ren Z; Fan M; Zhang J; Qi H; Xu M
Colloids Surf B Biointerfaces; 2019 Nov; 183():110452. PubMed ID: 31473409
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]